Nick Loman

Nick Loman
Name	Nick Loman
Occupation	Clinical microbiologist; bioinformatician; professor
Employer	University of Birmingham; Wellcome Sanger Institute
Alma mater	University of Birmingham; University of Oxford
Known for	Pathogen genomics; real-time sequencing; outbreak response

Nick Loman

Nick Loman is a British clinical microbiologist and bioinformatician known for pioneering work in pathogen genomics, real-time sequencing, and infectious disease outbreak response. He is associated with academic and research institutions that include the University of Birmingham and collaborative programmes connected to the Wellcome Sanger Institute. His work integrates high-throughput technologies, field-deployable sequencing, and computational tools to inform public health decisions during epidemics and routine surveillance.

Early life and education

Loman studied medicine and biological sciences at institutions including the University of Birmingham and trained in clinical microbiology with postgraduate affiliations that connected to the University of Oxford and clinical teaching hospitals such as Queen Elizabeth Hospital, Birmingham and regional pathology services. During his doctoral and postdoctoral development he collaborated with researchers from the Wellcome Trust, the Wellcome Sanger Institute, and the Medical Research Council. He received formal training that combined clinical laboratory practice at the National Health Service affiliated centres and computational genomics training with groups linked to the European Molecular Biology Laboratory and the Broad Institute.

Career

Loman has held academic posts at the University of Birmingham and has been an investigator collaborating with the Wellcome Sanger Institute, the Centers for Disease Control and Prevention, and the World Health Organization. He founded and led research groups that interfaced with consortia such as the COVID-19 Genomics UK Consortium and the Global Microbial Identifier initiative, while partnering with technology companies including Oxford Nanopore Technologies and sequencing centres like the J. Craig Venter Institute. His career spans roles in clinical diagnostics at hospital laboratories, leadership within university departments, and participation in multinational surveillance programmes involving agencies such as Public Health England and the European Centre for Disease Prevention and Control. He has contributed to training and capacity building through workshops with universities including Harvard University and Imperial College London.

Research contributions

Loman's research focuses on pathogen whole-genome sequencing, bioinformatic pipelines, and applications of portable sequencing platforms for rapid molecular epidemiology. He has developed and co-authored software and analytical methods used by laboratory networks, collaborating with teams from the Wellcome Trust Sanger Institute, National Institutes of Health, and the European Bioinformatics Institute. His group has published methodological advances that intersect with studies by investigators at Stanford University, University of Cambridge, and University of Oxford, addressing challenges in sequencing accuracy, consensus assembly, and variant detection for pathogens including Escherichia coli, Mycobacterium tuberculosis, Staphylococcus aureus, Zika virus, Ebola virus, and SARS-CoV-2. He has worked on benchmarking exercises in coordination with the Global Influenza Surveillance and Response System and contributed to frameworks for genomic data sharing advanced by initiatives at the Wellcome Trust and the Bill & Melinda Gates Foundation.

Public health and outbreak response

Loman has been active in deploying sequencing during outbreaks such as the 2014 West African Ebola virus epidemic, the 2016 Zika virus epidemic, and the COVID-19 pandemic. He has collaborated with public health agencies including Public Health England, the Centers for Disease Control and Prevention, and the World Health Organization to implement real-time genomic surveillance in field and laboratory settings. His work has intersected with emergency response teams from organizations like Médecins Sans Frontières and national laboratories in West Africa and Latin America, supporting contact tracing, transmission mapping, and infection control through portable technologies produced by companies such as Oxford Nanopore Technologies. He has contributed to operational guidelines used by the European Centre for Disease Prevention and Control and training materials adopted by university programmes at University College London and London School of Hygiene & Tropical Medicine.

Awards and recognition

Loman's contributions have been recognized through awards, invited keynote lectures, and leadership roles within professional societies such as the Microbiology Society and international genomic consortia. He has received research funding and honors from funders and institutions including the Wellcome Trust, the Medical Research Council, and the National Institute for Health Research. His publications have been widely cited in journals associated with publishers such as Nature, Science, and the Lancet family, and he has been profiled in science outreach venues connected to the Royal Society and media outlets that cover biomedical innovation.

Personal life and interests

Outside his professional roles Loman engages with scientific communication, open-science advocacy, and training initiatives that collaborate with educational institutions like the University of Birmingham, Imperial College London, and University of Oxford. He participates in workshops, conferences, and community events hosted by organisations such as the Wellcome Trust and the Royal Society of Biology, and has interests that include applied bioinformatics, technology translation, and capacity building in global health laboratories.

Category:British microbiologists Category:Bioinformaticians